Showing 1-5 of 36 :
OM1 Launches HS Dataset to Expand Use of Real-World Evidence in Dermatology

Practical Dermatology September 22, 2023 Read the full article >> OM1 is expanding its Dermatology Network to include almost 26,000 hidradenitis suppurativa (HS) patient records. “HS patients benefit when all available information on their journey can be surfaced and used to improve care and decision-making,” Joseph Zabinski tells DermWire. He is the Managing Director of AI and  Personalized Medicine at OM1. “Much of this[…]

The 2023 PharmaVoice 100 Awards Dr. Carl Marci

PharmaVoice Sept. 19. 2023 Read the full article >> The mental health crisis in the U.S. has reached a fever pitch with an estimated one in five adults experiencing some form of mental illness, according to the NIH. For Dr. Carl Marci, the dire need for new mental health solutions has propelled him throughout his 30-year[…]

Leveraging Real-World Data for Precision Obesity Treatment

Listen to the full podcast >> Healtheconmoncs.com July 26, 2023 On this episode of tHEORetically speaking features Gary Curhan, Chief Medical Officer and Jessica Paulus, Vice President of Research at OM1, as they answer questions on Leveraging Real-World Data for Precision Obesity Treatment.

American Academy of Dermatology launches innovative project to improve outcomes for patients with life-threatening pustular psoriasis

June 22, 2023 newswise Read the full release >> Newswise — Rosemont, Ill. (June 22, 2023) – The American Academy of Dermatology, with critical support from Boehringer Ingelheim, and powered by OM1’s data aggregation system and its PhenOM™ artificial intelligence (AI) platform, is launching an innovative breakthrough project to develop educational resources to improve the evaluation, diagnosis,[…]

1 2 3 … 8